Stephen Basil Thomas
Insider
First SEC filing: June 8, 2026 · Latest: June 8, 2026
Insider at
Insider transactions
0 buys (P)
5 sells (S)
Net: $-2,245,963
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 15, 2026 | CLYM | S 10b5-1 | 100,000 | $13.67 | $1,367,000 | 467,969 Direct | -17.61% | Disposed | -20.0% (price as of 2026-10-02) |
| June 5, 2026 | CLYM | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Feb. 26, 2026 | CLYM | S 10b5-1 | 16,313 | $7.01 | $114,354 | 154,657 Direct | -9.54% | Disposed | 56.1% (price as of 2026-10-02) |
| Feb. 25, 2026 | CLYM | S 10b5-1 | 33,687 | $7.00 | $235,809 | 170,970 Direct | -16.46% | Disposed | 56.3% (price as of 2026-10-02) |
| Feb. 13, 2026 | CLYM | S 10b5-1 | 10,000 | $5.81 | $58,100 | 204,657 Direct | -4.66% | Disposed | 88.3% (price as of 2026-10-02) |
| Feb. 12, 2026 | CLYM | S 10b5-1 | 90,000 | $5.23 | $470,700 | 214,657 Direct | -29.54% | Disposed | 109.2% (price as of 2026-10-02) |
| Aug. 7, 2025 | CLYM | A | 100,375 | · | · | 304,657 Direct | +49.14% | Acquired | (price as of 2026-10-02) |
| June 27, 2025 | CLYM | M | 25,094 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 27, 2025 | CLYM | M | 25,094 | · | · | 204,282 Direct | +14.00% | Acquired | (price as of 2026-10-02) |
| June 4, 2025 | CLYM | A | 40,000 | · | · | 40,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 27, 2025 | CLYM | M | 25,093 | · | · | 25,094 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| March 27, 2025 | CLYM | M | 25,093 | · | · | 179,188 Direct | +16.28% | Acquired | (price as of 2026-10-02) |
| Jan. 1, 2025 | CLYM | M | 50,188 | · | · | 50,187 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Jan. 1, 2025 | CLYM | M | 50,188 | · | · | 154,095 Direct | +48.30% | Acquired | (price as of 2026-10-02) |
| June 27, 2024 | CLYM | A | 100,375 | · | · | 100,375 Direct | · | Acquired | (price as of 2026-10-02) |
| June 27, 2024 | CLYM | A | 103,907 | · | · | 103,907 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 5, 2026 | CLYM | Stock Option (Right to Buy) | Common Stock | $10.55 | June 4, 2036 | 40,000 | Acquired |
| June 27, 2025 | CLYM | Restricted Stock Units | Common Stock | · | · | 25,094 | Disposed |
| June 4, 2025 | CLYM | Stock Option (Right to Buy) | Common Stock | $1.29 | June 3, 2035 | 40,000 | Acquired |
| March 27, 2025 | CLYM | Restricted Stock Units | Common Stock | · | · | 25,093 | Disposed |
| Jan. 1, 2025 | CLYM | Restricted Stock Units | Common Stock | · | · | 50,188 | Disposed |
| June 27, 2024 | CLYM | Restricted Stock Units | Common Stock | · | · | 100,375 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).